Aug 12, 2024, 02:14
Yale Cancer Center – Lymphir offers hope for Skin Disease in cutaneous T-cell lymphoma
Yale Cancer Center shared on X:
“‘Given the long-term nature [of cutaneous T-cell lymphoma], it is vital to get skin involvement under control. Lymphir is the 1st therapeutic option in many years to offer hope of decreasing skin disease.’-Dr. Francine Foss.”
Read further.
Source: Yale Cancer Center/X
Aug 12, 2024, 04:06